LO-TROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lo-trol, and what generic alternatives are available?
Lo-trol is a drug marketed by Vangard and is included in one NDA.
The generic ingredient in LO-TROL is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LO-TROL?
- What are the global sales for LO-TROL?
- What is Average Wholesale Price for LO-TROL?
Summary for LO-TROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Patent Applications: | 60 |
| DailyMed Link: | LO-TROL at DailyMed |
US Patents and Regulatory Information for LO-TROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vangard | LO-TROL | atropine sulfate; diphenoxylate hydrochloride | TABLET;ORAL | 088009-001 | Mar 25, 1983 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
